Manu Jain

11.8k total citations · 2 hit papers
95 papers, 3.5k citations indexed

About

Manu Jain is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Manu Jain has authored 95 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Pulmonary and Respiratory Medicine, 19 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Manu Jain's work include Cystic Fibrosis Research Advances (26 papers), Neonatal Respiratory Health Research (18 papers) and Respiratory Support and Mechanisms (12 papers). Manu Jain is often cited by papers focused on Cystic Fibrosis Research Advances (26 papers), Neonatal Respiratory Health Research (18 papers) and Respiratory Support and Mechanisms (12 papers). Manu Jain collaborates with scholars based in United States, India and Philippines. Manu Jain's co-authors include Alan R. Hauser, G. R. Scott Budinger, Susanna A. McColley, Navdeep S. Chandel, Maskit Bar‐Meir, Gökhan M. Mutlu, Grant S. Schulert, Carol Feghali‐Bostwick, Salman Khan and Lance R. Peterson and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Manu Jain

89 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mitochondrial Reactive Oxygen Species Regulate Transforming Growth Factor-β Signaling

2012 309 citations Manu Jain, Eleanor Rivera et al. profile →
Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study

2023 82 citations Steven M. Rowe, Jonathan B. Zuckerman et al. Journal of Cystic Fibrosis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Manu Jain United States	31	1.5k	1.4k	441	377	290	95	3.5k
Jieming Qu China	29	999 0.7×	1.6k 1.2×	291 0.7×	587 1.6×	395 1.4×	116	4.0k
Soichi Arakawa Japan	38	901 0.6×	1.3k 1.0×	362 0.8×	892 2.4×	1.3k 4.5×	298	5.0k
James F. Chmiel United States	36	3.0k 2.0×	800 0.6×	234 0.5×	556 1.5×	211 0.7×	81	4.4k
G. Bellon France	24	2.1k 1.4×	1.3k 1.0×	405 0.9×	371 1.0×	266 0.9×	96	3.3k
Akito Terai Japan	38	1.3k 0.9×	682 0.5×	373 0.8×	727 1.9×	1.2k 4.2×	192	4.6k
Steven E. Brooks United States	29	314 0.2×	576 0.4×	685 1.6×	527 1.4×	324 1.1×	128	3.2k
G. Lenoir France	31	1.3k 0.9×	444 0.3×	122 0.3×	548 1.5×	299 1.0×	126	2.8k
Rachel J. Gibson Australia	48	4.0k 2.7×	1.8k 1.3×	62 0.1×	327 0.9×	587 2.0×	118	6.5k
Harry W. Flynn United States	73	298 0.2×	1.9k 1.4×	171 0.4×	1.1k 2.9×	655 2.3×	591	20.6k
Deepak Narayan United States	27	271 0.2×	1.1k 0.8×	210 0.5×	696 1.8×	795 2.7×	133	3.9k

Countries citing papers authored by Manu Jain

Since Specialization

Citations

This map shows the geographic impact of Manu Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manu Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manu Jain more than expected).

Fields of papers citing papers by Manu Jain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manu Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manu Jain. The network helps show where Manu Jain may publish in the future.

Co-authorship network of co-authors of Manu Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Manu Jain. A scholar is included among the top collaborators of Manu Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manu Jain. Manu Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nelson, R., Zasu M. Klug, Alvaro Donayre, et al.. (2025). Remote analysis and management of sweat biomarkers using a wearable microfluidic sticker in adult cystic fibrosis patients. Proceedings of the National Academy of Sciences. 122(33). e2506137122–e2506137122. 3 indexed citations

Keens, Thomas G., Ia Topuria, Maria Berdella, et al.. (2024). Real-world effectiveness of elexacaftor/tezacaftor/ivacaftor on the burden of illness in adolescents and adults with cystic fibrosis. Heliyon. 10(7). e28508–e28508. 5 indexed citations

Rowe, Steven M., Jonathan B. Zuckerman, Daniel Dorgan, et al.. (2023). Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study. Journal of Cystic Fibrosis. 22(4). 656–664. 82 indexed citations breakdown →

Farabi, Banu, et al.. (2023). The role of reflectance confocal microscopy in the diagnosis and management of pigmentary disorders: A review. Journal of Cosmetic Dermatology. 22(12). 3213–3222. 9 indexed citations

Citters, Aricca D. Van, Peter Scalia, Christopher F. Dowd, et al.. (2021). Barriers and facilitators to implementing telehealth services during the COVID-19 pandemic: A qualitative analysis of interviews with cystic fibrosis care team members. Journal of Cystic Fibrosis. 20. 23–28. 21 indexed citations

Sala, Marc A., Michael Alexander, Yuliya Politanska, et al.. (2021). The proteostatic network chaperome is downregulated in F508del homozygote cystic fibrosis. Journal of Cystic Fibrosis. 20(2). 356–363. 3 indexed citations

Hoff, Brian M, et al.. (2021). Defining the Importance of Age-Related Changes in Drug Clearance to Optimizing Aminoglycoside Dosing Regimens for Adult Patients with Cystic Fibrosis. European Journal of Drug Metabolism and Pharmacokinetics. 47(2). 199–209. 3 indexed citations

Williams, Wadsworth A., Manu Jain, Theresa A. Laguna, & Susanna A. McColley. (2020). Preferences for disclosing adverse childhood experiences for children and adults with cystic fibrosis. Pediatric Pulmonology. 56(5). 921–927. 2 indexed citations

Jain, Manu & Christopher H. Goss. (2014). Update in Cystic Fibrosis 2013. American Journal of Respiratory and Critical Care Medicine. 189(10). 1181–1186. 19 indexed citations

10.

Jain, Manu & Navdeep S. Chandel. (2013). Rethinking Antioxidants in the Intensive Care Unit. American Journal of Respiratory and Critical Care Medicine. 188(11). 1283–1285. 23 indexed citations

11.

Clancy, John P. & Manu Jain. (2012). Personalized Medicine in Cystic Fibrosis: Dawning of a New Era. American Journal of Respiratory and Critical Care Medicine. 186(7). 593–597. 64 indexed citations

12.

Wei, Jun, Swati Bhattacharyya, Manu Jain, & John Varga. (2012). Regulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-γ: A Novel Link Between Metabolism and Fibrogenesis. The Open Rheumatology Journal. 6(1). 103–115. 44 indexed citations

13.

Jain, Manu, G. R. Scott Budinger, Daniela Urich, et al.. (2011). Leptin Promotes Fibroproliferative Acute Respiratory Distress Syndrome by Inhibiting Peroxisome Proliferator–activated Receptor-γ. American Journal of Respiratory and Critical Care Medicine. 183(11). 1490–1498. 88 indexed citations

14.

Jain, Manu, Anna P. Lam, & Cara J. Gottardi. (2011). Tissue-Specific Knockout/Knockdown of Type 2 TGF-β Receptor and Protection against Bleomycin Injury/Fibrosis. American Journal of Respiratory and Critical Care Medicine. 184(8). 983–983. 3 indexed citations

15.

Spragg, Roger G., Gordon R. Bernard, William Checkley, et al.. (2010). Beyond Mortality: Future Clinical Research in Acute Lung Injury. American Journal of Respiratory and Critical Care Medicine. 181(10). 1121–1127. 216 indexed citations

16.

Budinger, G. R. Scott, Gökhan M. Mutlu, Daniela Urich, et al.. (2010). Epithelial Cell Death Is an Important Contributor to Oxidant-mediated Acute Lung Injury. American Journal of Respiratory and Critical Care Medicine. 183(8). 1043–1054. 91 indexed citations

17.

Jain, Manu & Thomas Corbridge. (2000). Status asthmaticus: Strategies for stabilization after intubation. 15(6). 330–338. 1 indexed citations

18.

McColley, Susanna A., Veronica Stellmach, Steven R. Boas, Manu Jain, & Susan E. Crawford. (2000). Serum Vascular Endothelial Growth Factor Is Elevated in Cystic Fibrosis and Decreases with Treatment of Acute Pulmonary Exacerbation. American Journal of Respiratory and Critical Care Medicine. 161(6). 1877–1880. 78 indexed citations

19.

Das, Raman M, Manu Jain, & William M. Thurlbeck. (1979). Diurnal variation of deoxyribonucleic acid synthesis in murine alveolar wall cells and airway epithelial cells.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 119(1). 81–5. 4 indexed citations

20.

Jain, Manu, et al.. (1970). Webbed penis: A rare case. Kathmandu University Medical Journal. 8(1). 95–96. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact